A review of the neurotrophic and neuroprotective properties of ONO-1603: Comparison with those of tetrahydroaminoacridine, an antidementia drug

CNS Drug Reviews

Volumn 6, Issue 1, 2000, Pages 21-34

  Katsube, Nobuo ^a   Ishitani, Ryoichi ^b  

^a ONO PHARMACEUTICAL CO   (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

Antidementia drug; Apoptosis; Muscarinic receptor; Neuroprotection; Neurotrophic action; ONO 1603; Overexpression of GAPDH; Prolyl endopeptidase inhibitor

Indexed keywords

1 [N (4 CHLOROBENZYL)SUCCINAMOYL]PROLINAL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NOOTROPIC AGENT; PHYSOSTIGMINE; TACRINE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DIFFERENTIATION; CEREBELLUM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; GRANULE CELL; NERVE CELL; NEUROPROTECTION; NEUROTROPISM; REVIEW;

EID: 0034073298     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2000.tb00135.x     Document Type: Review

References (68)

1. Balázs R, Hack N, Jorgensen OS. Stimulation of the N-methyl-D-aspartate receptor has a trophic effect on differentiating cerebellar granule cells. Neurosci Lett 1988;87:80-86.
2. Bartus RT, Dean RL III, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-417.
3. Baxi MD, Vishwanatha JK. Uracil DNA glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding protein. Biochemistry 1995;34:9700-9707.
4. Burke JR, Enghild JJ, Martin ME, et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1996;2:347-350.
5. Buxbaum JD, Oishi M, Chen HI, et al. Cholinergic agonists and interleukin 1 regulate processing and release of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 1992;89:10075-10078.
6. Caswell AH, Corbett AM. Interaction of glyceraldehyde-3-phosphate dehydrogenase with isolated microsomal subfractions of skeletal muscle. J Biol Chem 1985;260:6892-6898.
7. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem 1995;65:1431-1444.
8. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 1983;219:1184-1190.
9. Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997;90:537-548.
10. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277:1990-1993.
11. Galli C, Piccini A, Ciotti MT, et al. Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis. Proc Natl Acad Sci USA 1998;95:1247-1252.
12. Gallo V, Ciotti MT, Coletti A, Aloisi F, Levi D. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc Natl Acad Sci USA 1982;79:7919-7923.
13. Gallo V, Kingsbury A, Balázs R, Jorgensen OS. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J Neurosci 1987;7:2203-2213.
14. Hardy J, Gwinn-Hardy K. Genetic clarification of primary neurodegenerative disease. Science 1998;282:1075-1079.
15. Huber G, Martin JR, Loffler J, Moreau JL. Involvement of amyloid precursor protein in memory formation in the rat: An indirect antibody approach. Brain Res 1993;603:348-352.
16. Igarashi S, Koide R, Shimohata T, et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 1998;18:111-117.
17. Ishitani R, Chuang D-M. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci USA 1996;93:9937-9941.
18. Ishitani R, Kimura M, Sunaga K, Katsube N, Tanaka M, Chuang D-M. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmacol Exp Ther 1996;278:447-454.
19. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang D-M. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar granule neurons in culture. J Neurochem 1996;66:928-935.
20. +-induced apoptosis but not necrosis of cultured cerebellar granule cells. Mol Pharmacol 1997;51:542-550.
21. Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang D-M. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 1998;53:701-707.
22. Katsube N, Tateishi N, Matsushita Y, et al. Anti-amnesic effect of ONO-1603, a novel prolyl endopeptidase inhibitor. Jpn J Pharmacol 1989;49:S98.
23. Katsube N, Maegawa H, Kagamiishi Y, Yamamoto M, Aishita H. ONO-1603 inhibits brain prolyl oligopeptidase in vitro, in vivo and in situ. Soc Neurosci Abstr 1994;20:1148.
24. Katsube N, Tateishi N, Ohuchida S. Prolyl oligopeptidase inhibitor: ONO-1603. Proceedings of the Second Symposium on Medicinal Chemistry: Approaches to Akheimer's Disease 1995:92-95.
25. 3-muscarinic receptor mRNA levels in differentiating rat cerebellar granule neurons. Neurosci Lett 1996;214:151-154.
26. Katsube N, Sunaga K, Aishita H, Chuang D-M, Ishitani R. ONO-1603, a potential antidementia drug, delays age-induced apoptosis and suppresses overexpression of glyceraldehyde-3-phosphate dehydrogenase in cultured central nervous system neurons. J Pharmacol Exp Ther 1999;288:6-13.
27. Kim T-W, Tanzi RE. Neuronal intranuclear inclusions in polyglutamine diseases: Nuclear weapons or nuclear fallout? Neuron 1998;21:657-659.
28. Koshy B, Matilla T, Burright EN, et al. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 1996;5:1311-1318.
29. Kragten E, Lalande I, Zimmermann K, et al. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J Biol Chem 1998;273:5821-5828.
30. Lee RKK, Wurtman RJ, Cox AJ, Nitsch RM. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc Natl Acad Sci USA 1995;92:8083-8087.
31. Lin WW, Wang CW, Chuang D-M. Effects of depolarization and NMDA antagonists on the survival of cerebellar granule cells: A pivotal role for protein kinase C isoforms. J Neurochem 1997;68:2577-2586.
32. Mason RP, Leeds PR, Jacob RF, et al. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J Neurochem 1999;72:1448-1456.
33. Mattson MP. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 1997;77:1081-1132.
34. Meyer-Siegler K, Mauro DJ, Seal G, Wurzer JC, de Riel JK, Sirover MA. A human nuclear uracil DNA glycosylase is the 37 kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci USA 1991;88:8460-8464.
35. Mills J, Reiner PB. Regulation of amyloid precursor protein cleavage. J Neurochem 1999;72:443-460.
36. Morgenegg G, Winkler GC, Hübscher U, Heizmann CW, Mous J, Kuenzle CC. Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J Neurochem 1986;7:54-2.
37. Nicoletti F, Wroblewski JT, Novelli A, Alho H, Guidotti, A, Costa E. The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J Neurosci 1986;6:1905-1911.
38. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992;258:304-307.
39. 2C receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem 1996;271:4188-4194.
40. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991;4:453-501.
41. Paulson HL, Perez MK, Trottier Y, et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997;19:333-344.
42. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995;15:3775-3787.
43. Robbins AR, Ward RD, Oliver C. A mutation in glyceraldehyde-3-phosphate dehydrogenase alters endocytosis in CHO cells. J Cell Biol 1995;130:1093-1104.
44. Roch JM, Masliah E, Roch-Levecq AC, et al. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc Natl Acad Sci USA 1994;91:7450-7454.
45. Rogers SL, Friedhoff LT, The Donepezil Study Group. The efficacy and safety of donepezil in patient with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 1996;7:293-303.
46. Sawa A, Khan AA, Hester LD, Snyder SH. Glyceraldehyde-3-phosphate dehydrogenase: Nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 1997;94:11669-11674.
47. Schulze H, Schuler A, Stüber D, Döbeli H, Langen H, Huber G. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's β-amyloid precursor protein. J Neurochem 1993;60:1915-1922.
48. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991;6:487-498.
49. Selkoe DJ. Alzheimer's disease: Genotypes, phenotypes and treatments. Science 1997;275:630-631.
50. Shashidharan P, Chalmers-Redman RME, Carlile GW, et al. Nuclear translocation of GAPDH-GFP fusion protein during apoptosis. Neuroreport 1999;10:1149-1153.
51. Singh R, Green MR. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 1993;259:365-368.
52. Sirover MA. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. J Cell Biochem 1997;66:133-140.
53. Sisodia SS. Nuclear inclusions in glutamine repeat disorders: Are they pernicious, coincidental, or beneficial? Cell 1998;95:1-4.
54. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 1994;5:2529-2533.
55. Suh Y-H. An etiological role of amyloidogenic carboxyl-terminal fragments of the β-amyloid precursor protein in Alzheimer's disease. J Neurochem 1997;68:1781-1791.
56. Summers WK, Majovski LV, Marsch GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 1986;315:1241-1245.
57. Sunaga K, Chuang D-M, Ishitani R. Autoradiographic demonstration of an increase in muscarinic cholinergic receptors in cerebellar granule cells treated with tetrahydroaminoacridine. Neurosci Lett 1993;151:45-47.
58. 2-, muscarinic acetylcholine receptor mRNA levels in differentiating cerebellar granule cells. Neurosci Lett 1993;163:27-30.
59. Sunaga K, Chuang D-M, Ishitani R. Tetrahydroaminoacridine is neurotrophic and promotes the expression of muscarinic receptor-coupled phosphoinositide turnover in differentiating cerebellar granule cells. J Pharmacol Exp Ther 1993;264:463-468.
60. Sunaga K, Takahashi H, Chuang D-M, Ishitani R. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci Lett 1995;200:133-136.
61. Tajima H, Tsuchiya K, Yamada M, Kondo K, Katsube N, Ishitani R. Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs. Neuroreport 1999;10:2029-2033.
62. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
63. Ulas J, Weihmuller FB, Brunner LC, Joyce JN, Marshall JF, Cotman CW. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: An autoradiographic study. J Neurosci 1994;14:6317-6324.
64. Vaccarino FM, Alho H, Santi MR, Guidotti A. Coexistence of GABA receptors and GABA-modulin in primary cultures of rat cerebellar granule cells. J Neurosci 1987;7:65-76.
65. Wilk S. Prolyl endopeptidase. Life Sci 1983;33:2149-2157.
66. Winkler J, Suhr ST, Gage FH, Thal LJ, Fisher U. Essential role of neocortical acetylcholine in spatial memory. Nature 1995;375:484-487.
67. Xu J, Chuang D-M. Serotonergic, adrenergic and histaminergic receptors coupled to phospholipase C in cultured cerebellar granule cells of rat. Biochem Pharmacol 1987;36:2353-2358.
68. Zager EL, Black PM. Neuropeptides in human memory and learning processes. Neurosurgery 1985;17:355-369.